Hospira Inc. recalls Hospira — Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection, USP Carpuject U…
- Recall date
- May 22, 2024
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Hospira Inc., Hospira
Why it was recalled
Device & Drug Safety – Potential Packaging Defect — Defect
What was recalled
Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection, USP Carpuject Units
Read the official recall notice →
Get recall alerts
Free email alert whenever Hospira Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Hospira Inc., Hospira